Similar articles

• Diagnosis and treatment of uveal melanoma.

  Shields JA, Shields CL, De Potter P, Singh AD. Shields JA, et al. Semin Oncol. 1996 Dec;23(6):763-7. Semin Oncol. 1996. PMID: 8970600 Review.
• Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.

  Shildkrot Y, Wilson MW. Shildkrot Y, et al. Curr Opin Ophthalmol. 2009 Nov;20(6):504-10. doi: 10.1097/ICU.0b013e328330b549. Curr Opin Ophthalmol. 2009. PMID: 19644367 Review.
• Update on the management of posterior uveal melanoma.

  Zhao DY, Shields CL, Shields JA, Gunduz K. Zhao DY, et al. J Ophthalmic Nurs Technol. 1998 Mar-Apr;17(2):66-71. J Ophthalmic Nurs Technol. 1998. PMID: 9677975 Review.
• [Trends and developments in the management of malignant uveal melanoma].

  Lund OE. Lund OE. Klin Oczna. 1988 Apr-May;90(4-5):159-64. Klin Oczna. 1988. PMID: 3071651 German. No abstract available.
• Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.

  Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe'er J. Kaiserman N, et al. Br J Ophthalmol. 2009 Sep;93(9):1167-71. doi: 10.1136/bjo.2009.157701. Epub 2009 Jun 30. Br J Ophthalmol. 2009. PMID: 19570767